Skip to main content
. Author manuscript; available in PMC: 2016 Sep 20.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2015 Mar 5;15(7):443–449. doi: 10.1016/j.clml.2015.02.020

Table 2.

Pharmacokinetics of Debio1143, means ± standard deviation

Dose Day N Cmax [mg/l] Tmax° [h] T1/2 [h] AUC0-inf [mg*h/l]
100 mg 1 8 1.2 ± 0.7 2.6 5.0 ± 1.1 6.0 ± 3.5
5 8 8.3 ± 0.8 2.9 13.0 ± 2.9 8.5 ± 5.7

200 mg 1 12 3.0 ± 1.8 1.5 5.6 ± 0.9 18 ± 9
5 12 2.4 ± 1.3 1.5 18.0 ± 5.1 24 ± 14

300 mg 1 4 4.4 ± 1.7 1.2 4.9 ± 1.0 25 ± 12
5 4 2.5 ± 4.0 2.0 15.9 ± 3.4 24 ± 11

400 mg 1 4 9.5 ± 4.5 1.0 5.9 ± 1.4 55 ± 20
5 4 5.6 ± 1.8 2.5 25.5 ± 3.7 72 ± 20
°

Median